| Company Name: |
Lynnchem
|
| Tel: |
86-(0)29-85992781 17792393971 |
| Email: |
info@lynnchem.com |
| Products Intro: |
Product Name:Daclatasvir Impurity E
CAS:1009113-58-9
Purity:95% Package:5mg;25mg
|
| Company Name: |
Hubei Yangxin Medical Technology Co., Ltd.
|
| Tel: |
15374522761 |
| Email: |
3003392093@qq.com |
| Products Intro: |
Product Name:Daclatasvir Impurity 39
CAS:1009113-58-9
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
| Company Name: |
Novachemistry
|
| Tel: |
44-20819178-90 02081917890 |
| Email: |
info@novachemistry.com |
| Products Intro: |
Product Name:Daclatasvir Impurity E
CAS:1009113-58-9
Purity:95% Package:5mg;25mg
|
| Company Name: |
Cato Research Chemicals Inc.
|
| Tel: |
020-81215950 4000-868-328 |
| Email: |
customer@uwalab.com |
| Products Intro: |
Product Name:Daclatasvir Impurity 4
CAS:1009113-58-9
Purity:95%（HPLC） Package:10mg；25mg；50mg；100mg
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing1@energy-chemical.com |
| Products Intro: |
Product Name:Daclatasvir Diethyl Ester
CAS:1009113-58-9
Purity:NULL Package:100mg;10mg;5mg Remarks:NULL
|
|
| | Daclatasvir Impurity E Basic information |
| Product Name: | Daclatasvir Impurity E | | Synonyms: | Daclatasvir Impurity E;Daclatasvir Di-Ethyl Ester;Daclatasvir impurity 10/Daclatasvir Diethyl Ester/N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxoethyl]]]biscarbamic Acid C,C'-Diethyl Ester;Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxoethyl]]]bis-, C,C'-diethyl ester | | CAS: | 1009113-58-9 | | MF: | C42H54N8O6 | | MW: | 766.93 | | EINECS: | | | Product Categories: | | | Mol File: | 1009113-58-9.mol |  |
| | Daclatasvir Impurity E Chemical Properties |
| Boiling point | 1075.1±65.0 °C(Predicted) | | density | 1.228±0.06 g/cm3(Predicted) | | pka | 11.17±0.46(Predicted) |
| | Daclatasvir Impurity E Usage And Synthesis |
| Uses | Daclatasvir Diethyl Ester is an impurity of Daclatasvir (D101500); a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). |
| | Daclatasvir Impurity E Preparation Products And Raw materials |
|